<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>89(5)</volume><submitter>Taura M</submitter><pubmed_abstract>&lt;h4>Unlabelled&lt;/h4>The transcription factor NF-κB is important for HIV-1 transcription initiation in primary HIV-1 infection and reactivation in latently HIV-1-infected cells. However, comparative analysis of the regulation and function of NF-κB in latently HIV-1-infected cells has not been done. Here we show that the expression of IκB-α, an endogenous inhibitor of NF-κB, is enhanced by latent HIV-1 infection via induction of the host-derived factor COMMD1/Murr1 in myeloid cells but not in lymphoid cells by using four sets of latently HIV-1-infected cells and the respective parental cells. IκB-α protein was stabilized by COMMD1, which attenuated NF-κB signaling during Toll-like receptor ligand and tumor necrosis factor alpha treatment and enhanced HIV-1 latency in latently HIV-1-infected cells. Activation of the phosphoinositol 3-kinase (PI3K)-JAK pathway is involved in COMMD1 induction in latently HIV-1-infected cells. Our findings indicate that COMMD1 induction is the NF-κB inhibition mechanism in latently HIV-1-infected cells that contributes to innate immune deficiency and reinforces HIV-1 latency. Thus, COMMD1 might be a double-edged sword that is beneficial in primary infection but not beneficial in latent infection when HIV-1 eradication is considered.&lt;h4>Importance&lt;/h4>HIV-1 latency is a major barrier to viral eradication in the era of combination antiretroviral therapy. In this study, we found that COMMD1/Murr1, previously identified as an HIV-1 restriction factor, inhibits the proteasomal degradation of IκB-α by increasing the interaction with IκB-α in latently HIV-1-infected myeloid cells. IκB-α protein was stabilized by COMMD1, which attenuated NF-κB signaling during the innate immune response and enhanced HIV-1 latency in latently HIV-1-infected cells. Activation of the PI3K-JAK pathway is involved in COMMD1 induction in latently HIV-1-infected cells. Thus, the host-derived factor COMMD1 is beneficial in suppressing primary infection but enhances latent infection, indicating that it may be a double-edged sword in HIV-1 eradication.</pubmed_abstract><journal>Journal of virology</journal><pagination>2643-58</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4325709</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>COMMD1/Murr1 reinforces HIV-1 latent infection through IκB-α stabilization.</pubmed_title><pmcid>PMC4325709</pmcid><pubmed_authors>Kudo E</pubmed_authors><pubmed_authors>Goto H</pubmed_authors><pubmed_authors>McDonald F</pubmed_authors><pubmed_authors>Taura M</pubmed_authors><pubmed_authors>Kai H</pubmed_authors><pubmed_authors>Hattori S</pubmed_authors><pubmed_authors>Kariya R</pubmed_authors><pubmed_authors>Shuto T</pubmed_authors><pubmed_authors>Vaeteewoottacharn K</pubmed_authors><pubmed_authors>Suico MA</pubmed_authors><pubmed_authors>Matsuda K</pubmed_authors><pubmed_authors>Okada S</pubmed_authors></additional><is_claimable>false</is_claimable><name>COMMD1/Murr1 reinforces HIV-1 latent infection through IκB-α stabilization.</name><description>&lt;h4>Unlabelled&lt;/h4>The transcription factor NF-κB is important for HIV-1 transcription initiation in primary HIV-1 infection and reactivation in latently HIV-1-infected cells. However, comparative analysis of the regulation and function of NF-κB in latently HIV-1-infected cells has not been done. Here we show that the expression of IκB-α, an endogenous inhibitor of NF-κB, is enhanced by latent HIV-1 infection via induction of the host-derived factor COMMD1/Murr1 in myeloid cells but not in lymphoid cells by using four sets of latently HIV-1-infected cells and the respective parental cells. IκB-α protein was stabilized by COMMD1, which attenuated NF-κB signaling during Toll-like receptor ligand and tumor necrosis factor alpha treatment and enhanced HIV-1 latency in latently HIV-1-infected cells. Activation of the phosphoinositol 3-kinase (PI3K)-JAK pathway is involved in COMMD1 induction in latently HIV-1-infected cells. Our findings indicate that COMMD1 induction is the NF-κB inhibition mechanism in latently HIV-1-infected cells that contributes to innate immune deficiency and reinforces HIV-1 latency. Thus, COMMD1 might be a double-edged sword that is beneficial in primary infection but not beneficial in latent infection when HIV-1 eradication is considered.&lt;h4>Importance&lt;/h4>HIV-1 latency is a major barrier to viral eradication in the era of combination antiretroviral therapy. In this study, we found that COMMD1/Murr1, previously identified as an HIV-1 restriction factor, inhibits the proteasomal degradation of IκB-α by increasing the interaction with IκB-α in latently HIV-1-infected myeloid cells. IκB-α protein was stabilized by COMMD1, which attenuated NF-κB signaling during the innate immune response and enhanced HIV-1 latency in latently HIV-1-infected cells. Activation of the PI3K-JAK pathway is involved in COMMD1 induction in latently HIV-1-infected cells. Thus, the host-derived factor COMMD1 is beneficial in suppressing primary infection but enhances latent infection, indicating that it may be a double-edged sword in HIV-1 eradication.</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Mar</publication><modification>2024-11-13T01:04:00.917Z</modification><creation>2019-03-27T01:45:06Z</creation></dates><accession>S-EPMC4325709</accession><cross_references><pubmed>25520503</pubmed><doi>10.1128/JVI.03105-14</doi><doi>10.1128/jvi.03105-14</doi></cross_references></HashMap>